IRCT20200407046981N7招募中未知
Randomized, single-dose, crossover comparative bioequivalence study of the Erlotinib 150 mg tablets produced by Kimia pharmaceutical Co versus Tarceva® (Roche company) in 30 healthy males under fasting conditions
Kimia pharmaceutical Co0 个研究点目标入组 30 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- Male
入选标准
- •The weight limit for each volunteer between 60-100 kg.
- •All volunteers must be non-smokers.
- •They must be healthy in terms of liver, kidney, respiratory system, mental and other general health characteristics
排除标准
- •Known hypersensitivity or idiosyncratic reaction to Erlotinib or any ingredients.
- •Subjects with BP = 90/60 mm/Hg or BP = 140/90 mm/Hg
- •Taking any medicine during two week before dosing.
研究者
相似试验
已完成
不适用
bioequivalence study of Metformin 100 mg + Sitagliptin 50 mg tablets in 24 healthy male under fasting conditionsIRCT20180620040164N15Actover co24
尚未招募
不适用
Study of absorption and elimination rate of Esomeprazole 10 mg sachet in comparison with standard sachet of Esomeprazole (Nexium®).In this study, the disease is not examined. The subject of the study is the bioequivalence study of the Esomeprazole 10 mg of test and reference in healthy volunteers..IRCT20200407046981N12???? ???????? ????? ????? ????????24
招募中
Unknown
bioequivalence study of Gliclazide 30 mg MR tablet in 24 healthy male under fasting conditionsdiabetes mellitus.Type 1 diabetes mellitusIRCT20180620040164N53ACtover Pharmaceutical Co.24
招募中
不适用
Bioequivalence of a New Generic Formulation of Domperidone 1 mg/ml (200 mL) suspension produced by Razan pharmed Iranian pharmaceutical Co versus Motilium® after single dose administration to healthy volunteersIRCT20200407046981N10???? ???????? ????? ????? ????????24
招募中
不适用
Study of absorption and elimination rate of Meloxicam 15 mg tablets in comparison with standard tablets of Meloxicam (Mobic®).IRCT20200407046981N13Daana pharmaceutical company24